LFG
LKFT

Larson Financial Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Larson Financial Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.58K Sell
286
-2
-0.7% -$66 ﹤0.01% 2337
2025
Q4 		$9.42K Buy
288
+132
+85% +$4.26K ﹤0.01% 2146
2025
Q3 		$5.4K Buy
156
+96
+160% +$3.07K ﹤0.01% 2329
2025
Q2 		$1.68K Buy
+60
New +$1.61K ﹤0.01% 2476

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Larson Financial Group's LKFT Position: Q1 2026 in Review

Larson Financial Group reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 0.69% in Q1 2026, selling an estimated $66 and leaving 286 shares worth $8.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2337.

Larson Financial Group first reported a position in LKFT in Q2 2025 and has held it in 4 quarters since. The position peaked at $9.42K in Q4 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Larson Financial Group held 286 shares of Lakefront Biotherapeutics American Depositary Shares worth $8.58K as of Q1 2026.
  • Larson Financial Group sold 2 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $66.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2337 holding.
  • Larson Financial Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2025 and has held it in 4 quarters since.
  • Larson Financial Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $9.42K in Q4 2025.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.